Sign in
4

Changes in Ownership

Damora Therapeutics, Inc. Filed Acc 0001209191-23-001757

Options or other derivatives

  • Chief Business Officer acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Oestreich Stephanie Chief Business Officer 2023-01-04 Grant or award · Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X03/doc4.xml…